A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab

Recently, the efficacy of immuno-oncologic agents for advanced hepatocellular carcinoma (HCC) has been proven in several trials. In particular, atezolizumab with bevacizumab (AteBeva), as a first-line therapy for advanced HCC, has shown tremendous advances in the IMBrave150 study. However, second or...

Full description

Saved in:
Bibliographic Details
Main Authors: Hyung Jun Kim (Author), Sang Youn Hwang (Author), Jung Woo Im (Author), Ki Jeong Jeon (Author), Wan Jeon (Author)
Format: Book
Published: Korean Liver Cancer Association, 2023-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!